Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer; Lung Cancer; Nsclc; NSCLC Stage II; NSCLC, Stage III; Unclassified Renal Cell Carcinoma; Papillary Renal Cell Carcinoma; Fumarate Hydratase Deficient Renal Cell Carcinoma; Succinate Dehydrogenase Deficient Renal Cell Carcino ma; Collecting Duct Renal Cell Carcinoma; Chromophobe Renal Cell Carcinoma Interventions: Radiation: Radiation Therapy; Drug: Durvalumab Sponsor: Memorial Sloan Kettering Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Renal Cell Carcinoma | Research